Literature DB >> 23551094

Role of SHIP1 in cancer and mucosal inflammation.

Sandra Fernandes1, Sonia Iyer, William G Kerr.   

Abstract

The SH-2 containing inositol 5'-polyphosphatase 1 (SHIP1) is a multifunctional protein expressed predominantly, but not exclusively, by hematopoietic cells. SHIP1 removes the 5'-phosphate from the product of PI3K, PI(3,4,5)P₃, to generate PI(3,4)P₂. Both PIP species influence the activity level of Akt and ultimately regulate cell survival and differentiation. SHIP1 also harbors several protein interaction domains that endow it with many nonenzymatic cell signaling or receptor masking functions. In this review, we discuss the opposing roles of SHIP1 in cancer and in mucosal inflammation. On one hand, germline loss of SHIP1 causes myeloid lung consolidation and severe inflammation in the ileum, a phenotype that closely mimics human Crohn's disease and can be rescued by reconstitution with SHIP1-competent T cells. On the other, transient inhibition of the enzymatic activity of SHIP1 in cancer cells leads to apoptosis and enhances survival in lethal murine xenograft models. Overall, careful dissection of the different pathological mechanisms involved in several diseases provides novel opportunities for therapeutic intervention targeting SHIP1.
© 2013 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551094      PMCID: PMC3620675          DOI: 10.1111/nyas.12038

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.

Authors:  Q Liu; T Sasaki; I Kozieradzki; A Wakeham; A Itie; D J Dumont; J M Penninger
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

2.  Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses.

Authors:  Tomar Ghansah; Kim H T Paraiso; Steven Highfill; Caroline Desponts; Sarah May; Joseph K McIntosh; Jia-Wang Wang; John Ninos; Jason Brayer; Fengdong Cheng; Eduardo Sotomayor; William G Kerr
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

3.  Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell.

Authors:  Joseph A Wahle; Kim H T Paraiso; Robert D Kendig; Harshani R Lawrence; Liwei Chen; Jerry Wu; William G Kerr
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

4.  Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.

Authors:  Christopher J Ong; Andrew Ming-Lum; Matt Nodwell; Ali Ghanipour; Lu Yang; David E Williams; Joseph Kim; Loutfig Demirjian; Pooran Qasimi; Jens Ruschmann; Li-Ping Cao; Kewei Ma; Stephen W Chung; Vincent Duronio; Raymond J Andersen; Gerald Krystal; Alice L-F Mui
Journal:  Blood       Date:  2007-05-14       Impact factor: 22.113

5.  A pleckstrin homology-related domain in SHIP1 mediates membrane localization during Fcγ receptor-induced phagocytosis.

Authors:  Andrew Ming-Lum; Shaheen Shojania; Eva So; Erin McCarrell; Eileen Shaw; David Vu; Ida Wang; Lawrence P McIntosh; Alice L-F Mui
Journal:  FASEB J       Date:  2012-05-31       Impact factor: 5.191

6.  Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.

Authors:  Jia-Wang Wang; Julie M Howson; Tomar Ghansah; Caroline Desponts; John M Ninos; Sarah L May; Kim H T Nguyen; Noriko Toyama-Sorimachi; William G Kerr
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

7.  SHIP is required for a functional hematopoietic stem cell niche.

Authors:  Amy L Hazen; Michelle J Smith; Caroline Desponts; Oliver Winter; Katrin Moser; William G Kerr
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

8.  Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span.

Authors:  C D Helgason; J E Damen; P Rosten; R Grewal; P Sorensen; S M Chappel; A Borowski; F Jirik; G Krystal; R K Humphries
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

9.  Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.

Authors:  Jun Zhang; Scott F Walk; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

10.  Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.

Authors:  Christina Gewinner; Zhigang C Wang; Andrea Richardson; Julie Teruya-Feldstein; Dariush Etemadmoghadam; David Bowtell; Jordi Barretina; William M Lin; Lucia Rameh; Leonardo Salmena; Pier Paolo Pandolfi; Lewis C Cantley
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

View more
  16 in total

1.  Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.

Authors:  Jamil Mahmud; Michael J Miller; Aaron M Altman; Gary C Chan
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

2.  Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.

Authors:  Petra den Hollander; Kathryn Rawls; Anna Tsimelzon; Jonathan Shepherd; Abhijit Mazumdar; Jamal Hill; Suzanne A W Fuqua; Jenny C Chang; C Kent Osborne; Susan G Hilsenbeck; Gordon B Mills; Powel H Brown
Journal:  Cancer Res       Date:  2016-02-26       Impact factor: 12.701

3.  Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1: a meaningful and independent marker to predict stroke in the Chinese population.

Authors:  Wen-Jun Tu; Xiao-Ye Liu; Hao Dong; Yan Yu; Yi Wang; Hui Chen
Journal:  J Mol Neurosci       Date:  2013-12-19       Impact factor: 3.444

4.  Human Cytomegalovirus Induces an Atypical Activation of Akt To Stimulate the Survival of Short-Lived Monocytes.

Authors:  Olesea Cojohari; Megan A Peppenelli; Gary C Chan
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

Review 5.  Excitable networks controlling cell migration during development and disease.

Authors:  Xiaoguang Li; Yuchuan Miao; Dhiman Sankar Pal; Peter N Devreotes
Journal:  Semin Cell Dev Biol       Date:  2019-12-10       Impact factor: 7.727

Review 6.  Discovery and development of small molecule SHIP phosphatase modulators.

Authors:  William G Kerr; John D Chisholm; Dennis R Viernes; Lydia B Choi
Journal:  Med Res Rev       Date:  2013-12-02       Impact factor: 12.944

7.  Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.

Authors:  Shingo Nakahata; Tomonaga Ichikawa; Phudit Maneesaay; Yusuke Saito; Kentaro Nagai; Tomohiro Tamura; Nawin Manachai; Norio Yamakawa; Makoto Hamasaki; Issay Kitabayashi; Yasuhito Arai; Yae Kanai; Tomohiko Taki; Takaya Abe; Hiroshi Kiyonari; Kazuya Shimoda; Koichi Ohshima; Akira Horii; Hiroshi Shima; Masafumi Taniwaki; Ryoji Yamaguchi; Kazuhiro Morishita
Journal:  Nat Commun       Date:  2014-02-26       Impact factor: 14.919

Review 8.  Targeting SHIP1 and SHIP2 in Cancer.

Authors:  Chiara Pedicone; Shea T Meyer; John D Chisholm; William G Kerr
Journal:  Cancers (Basel)       Date:  2021-02-20       Impact factor: 6.639

9.  Inhibition of lipid phosphatase SHIP1 expands myeloid-derived suppressor cells and attenuates rheumatoid arthritis in mice.

Authors:  Eui-Young So; Changqi Sun; Keith Q Wu; Patrycja M Dubielecka; Anthony M Reginato; Olin D Liang
Journal:  Am J Physiol Cell Physiol       Date:  2021-07-21       Impact factor: 5.282

Review 10.  Role of inositol poly-phosphatases and their targets in T cell biology.

Authors:  Neetu Srivastava; Raki Sudan; William Garrow Kerr
Journal:  Front Immunol       Date:  2013-09-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.